Guobin Wang
- Immunology top 1%
- Immune Cell Function and Interaction 15
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 11
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 16
- Colorectal Cancer Surgical Treatments 13
- Colorectal Cancer Treatments and Studies 12
- Cancer Research top 2%
- Molecular Biology top 5%
- RNA Interference and Gene Delivery 15
-
- Gastric Cancer Management and Outcomes 17
-
- Nanoplatforms for cancer theranostics 14
- Cited by
- ImmunologyBiomaterialsOncology
- Partner nations
- ChinaUnited StatesPoland
In The Last Decade
Guobin Wang
216 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 159
- Immunology 2.0k
- Biomaterials 896
- Oncology 1.8k
- Cancer Research 980
- Molecular Biology 2.4k
Countries citing papers authored by Guobin Wang
This map shows the geographic impact of Guobin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guobin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guobin Wang more than expected).
Fields of papers citing papers by Guobin Wang
This network shows the impact of papers produced by Guobin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guobin Wang. The network helps show where Guobin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guobin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 26 | |
| 6 | 2020 | 7 | |
| 7 | 2019 | 8 | |
| 8 | 2019 | 27 | |
| 9 | 2018 | 326 | |
| 10 | 2015 | 213 | |
| 11 | 2015 | 1 | |
| 12 | 2014 | 2 | |
| 13 | 2013 | 13 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 39 | |
| 16 | The mini-invasive surgery for colorectal carcinoma with intestinal obstruction under enteroscope and laparoscope | 2011 | 0 |
| 17 | 2009 | 151 | |
| 18 | 2008 | 70 | |
| 19 | Diagnosis and treatment of 77 cases of gallbladder cancer | 2007 | 1 |
| 20 | Study of biology character of ovarian metastasis in gastric cancer | 2005 | 1 |
About Guobin Wang
Guobin Wang is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 225 papers that have together received 6.7k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (17 papers), Cancer Immunotherapy and Biomarkers (16 papers), RNA Interference and Gene Delivery (15 papers), Immune Cell Function and Interaction (15 papers), Nanoplatforms for cancer theranostics (14 papers), Colorectal Cancer Surgical Treatments (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Nanoparticle-Based Drug Delivery (11 papers). The work is most often cited by research in Immunology (2.0k citations), Biomaterials (896 citations) and Oncology (1.8k citations). Guobin Wang has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Lin Wang, Zheng Wang, Kaixiong Tao, Weiping Zou, Ke Wu, Ende Zhao, Ilona Kryczek, Luming Xu, Xiaoming Shuai and Kaixiong Tao. Their work appears in journals such as Oncotarget, Medicine, ACS Applied Materials & Interfaces, Biomaterials and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.